Overview

SPG Blocks for Headaches

Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
0
Participant gender:
All
Summary
This will be a single-center, open-label clinical trial comparing sphenopalatine ganglion blocks to standard intravenous therapy for patients who come to the emergency department for a headache.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kendall Healthcare Group, Ltd.
Collaborator:
Nova Southeastern University
Treatments:
Prochlorperazine
Criteria
Inclusion Criteria:

- Any patient at least 18 years old who presented to the ED with a suspected primary
headache.

Exclusion Criteria:

- pregnant women

- prisoners

- meningeal signs

- fever

- any acute abnormality on neurologic exam

- allergy to one of study drugs

- on oral anticoagulant

- already received analgesic treatment in the ED